TherapeuticsMD, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
TherapeuticsMD, Inc. (TXMD) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.67 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-23.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-23
- TherapeuticsMD, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $7.43M.
- TherapeuticsMD, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $7.67M.
- TherapeuticsMD, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2013 was $1.71M, a 427889.00% increase from fiscal 2012.
- TherapeuticsMD, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $400.00, a 99.79% decline from fiscal 2011.
- TherapeuticsMD, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2011 was $190.28K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|
| 2020-12-31 | $7.67M 10-K · filed 2022-03-23 | $7.67M 10-K · filed 2021-03-04 | ||
| 2020-09-30 | $7.43M 10-Q · filed 2021-11-12 | $7.43M 10-Q · filed 2020-11-09 | ||
| 2013-12-31 | $1.71M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $400.00 10-K · filed 2015-03-12 | |||
| 2011-12-31 | $190.28K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |